Equity Analysis /
United States of America

US : Biotechnology - Biotechnology | Valuation Dilution From Recent IPOs Exacerbated Cyclical Stress but Does Not Change the Conclusion

    Dane Leone
    Contributors
    Timur Ivannikov
    Danielle Brill
    Steven Seedhouse
    CGS-CIMB
    26 March 2022
    Published by